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308a Monday, February 17, 2014the downstream domains that lead into the transmembrane helix. To address
this issue, we have combined multiscale molecular dynamics (MD) simulations
with biophysical assays to study the extracellular region of EphA2 upstream of
the transmembrane helix, the fibronectin domain 2 (FN2). A number of novel
insights emerged: (i) the FN2 domain can interact with the membrane, (ii) this
domain preferentially interacts with anionic lipids, (iii) this preference is main-
tained through a positively charged surface of the protein, including K441 and
R443. The study allows us, for the first time, to combine the recently emerged
X-ray crystallography with NMR models of the transmembrane region. We
present a full atomistic model of an Eph signalling cluster (extracellular regions
and transmembrane regions) assembled at a model cell membrane composed of
a lipid mixture. This work is a significant step in understanding the formation of
Eph signalling clusters and paves the way towards understanding the assembly
of full length Eph receptor platforms at the surface of cells.
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DiC14-amidine is a cationic lipid which induces pro-inflammatory cytokine
secretion in immune cells upon interaction with the Toll-like receptor 4
(TLR4)/Myeloid Differentiation factor-2 (MD-2) membrane bound-complex,
the natural sensor of bacterial lipopolysaccharides (LPS) [1-3].
The aim of the present work is to characterize the interaction between diC14-
amidine and the TLR4/MD2 receptor complex. Taking advantage of the
species-dependent activity of TLR4 agonists [4], we compared the TLR4
agonist activity of diC14-amidine in four different species in order to map do-
mains in TLR4 and MD2 that are important for diC14-amidine TLR4-agonist
activity. We demonstrate that, while LPS is an agonist in all species, diC14-
amidine is a full agonist for human, mouse and cat receptors, but a poor agonist
for horse. Using chimeric constructs made from human and horse TLR4 and
single mutants, we identify two regions in the human TLR4 that modulates
the agonist activity of diC14-amidine. Interestingly, these regions in TLR4
are different from the previously identified bacterial lipopolysaccharides bind-
ing domains [5]. How ligand binding to two different regions of the same recep-
tor affects the cellular pathways is currently under investigation.
[1] Tanaka, T. et al. (2008) Eur.J.Immunol. 38: 1351-1357.
[2] Lonez, C. Et al. (2008) Prog Lipid Res. 47:340-7.
[3] Lonez, C; et al. (2012) Adv Drug Deliv Rev. 64:1749-58.
[4] Walsh, C. et al. (2008) J.Immunol. 181: 1245-1254.
[5] Park, B. S. et al. (2009) Nature 458: 1191-1195.
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Unregulated activation of kinases leads to aberrant signaling, uncontrolled
growth, and differentiation of cancerous cells. Reaching a complete mecha-
nistic understanding of the large scale conformational transformations underly-
ing the activation of kinases could greatly help in the development of
therapeutic drugs for the treatment of these pathologies. In princi- ple, the na-
ture of conformational transition could be modeled by in silico via atomistic
molecular dynamics simulations, although this is very challenging due to the
long timescales (100s of ms) associated with activation. In this study, we
employ a computational paradigm that cou-
ples transition pathway generation tech-
niques and Markov State Model (MSM)
based massively (total simulation time of
~3 milliseconds) distributed simulations
for mapping the conformational landscape
of several key tyrosine kinases. The com-
putations provide the thermodynamics and
kinetics of kinase activation for the first
time, and help identify key intermediates
along the activation pathway. Furthermore,
the presence of a novel allosteric sites in an
intermediate states of kinases that could be
potentially utilized for drug design is
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Opioid receptors are classical pharmacological targets and the object of intense
research towards improved analgesics with reduced side effects. High-
resolution X-ray crystal structures of all four opioid receptor subtypes - the
mu (MOP), kappa (KOP), delta (DOP), and nociceptin (NOP) opioid receptors -
have recently provided direct information about the molecular determinants of
opioid binding affinity. Yet, little information is available about the kinetics of
opioid-receptor binding, which may be as important as, or even more important
than, affinity for the rational design of efficacious opioid-based therapeutics.
By accelerating transitions between low-energy states, enhanced molecular dy-
namics techniques are especially suited to gain atomic-level insight into opioid
receptor recognition and binding. Here, we used multiple-walker well-
tempered metadynamics to investigate the binding of classical opioid receptor
ligands to the mouse MOP receptor. We find that the first interaction between
the ligand and MOP involves residue D218 in the extracellular loop 2 and res-
idues of transmembrane (TM) helix 2. Analysis of the lowest-energy binding
pathways reveals an additional intermediate metastable state in which the
ligand positions itself in a region that is partially occupied by JDTic in the cor-
responding KOP crystal structure, forming interactions with residues in TM2
and TM3.
We used the free-energies resulting from our simulations to derive estimates of
binding affinity and transition rates along the characterized opioid binding
pathways, as well as ligand on- and off-rates. Given the reasonable agreement
between the calculated estimates and published experimental values, and the
provided powerful insights into molecular determinants of opioid-receptor
binding kinetics, these types of simulation hold great promise for the rational
design of opioids with desired binding kinetics.
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There has been a great need for computational prediction of G-protein coupled
receptor (GPCR) structures, especially those in their active states, in order to
assist drug discovery. However, the active state conformation prediction is
challenging not only because of the lack of homology templates derived
from the existing active state X-ray structures, but also because of the high
energy nature of the active conformations. In addition, experimental evidence
suggests that a GPCR can have many different active states, but the existing
several crystal structures usually only capture one of those states for each
GPCR. Here we present a method to make the GPCR active state structural
prediction possible, and our method can discover a number of active states
for each GPCR. Instead of the traditional homology modeling, we used a tem-
plate from mixed sources and sampled a discrete set of orientations of the
seven transmembrane helices of the GPCR to locate structures that are likely
to be in the active-state valley on the energy surface. Next, we did a local
conformational sampling to find structures at the local minima of the
active-state potential energy valleys. We have benchmarked the method
with human b2 adrenergic receptor, which has both its active and inactive
state structures crystalized. Then we applied the method on a GPCR with un-
known structure, the human somatostatin receptor subtype 5 (hSSTR5). Dock-
ing of agonists and antagonists to the predicted active and inactive state
structures of hSSTR5 gave the expected result that antagonists favor the inac-
tive state structures, while the agonists could not distinguish the inactive and
active state structures without the presence of G proteins. In the end, we were
able to build a model picture of hSSTR5 function consistent with experi-
mental findings.
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Plexins are transmembrane receptors that receive guidance cues (such as bind-
ing of Semaphorin ligands) and are activated by them, functioning in cell
migration processes in neuronal and cardiovascular development, but also in
cancer metastasis. Plexins are unique, as they are the first example of a receptor
that interacts directly with small GTPases, a family of proteins that are essential
for cell motility and proliferation/survival. We previously determined the
